Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. In the United Kingdom, ...

Researchers have used cerebrospinal fluid to identify proteins and genes linked to Alzheimer’s disease, revealing potential ...

A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan targeting proteins in the brains of sufferers of the debilitating disease, will cost 3.08 ...

A once-a-day pill that targets the production of the stress hormone cortisol in the brain has the potential to be the “holy ...

European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

Frailty is associated with an increased risk for dementia, new findings showed, with an acceleration of frailty observed 4-9 years prior to dementia onset.

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...

For a healthy brain as we age, we need healthy blood pressure. However, nearly half of American adults have hypertension, ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...